Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1982-10-04
1986-01-07
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
2601125R, C07C10352, A61K 3702
Patent
active
045633525
ABSTRACT:
Human pancreatic GRF has been synthesized. The invention provides synthetic peptides which are extremely potent in stimulating the release of pituitary GH in mammals and which have the formula: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-R.sub.15 -Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-S er-Asn-Gln-Glu-Arg-Gly-R.sub.40 -R.sub.41 -R.sub.42 -Y wherein R.sub.15 is Gly or D-Ala, R.sub.40 is Ala or des-R.sub.40, R.sub.41 is Phe or des-R.sub.41, R.sub.42 is des-R.sub.42 or 1 to 8 different amino acid residues selected from the group consisting of Gln, Gly, Ile, Leu, Lys, Pro, Thr and Val, and Y signifies the carboxyl moiety of the amino acid residue at the C-terminal and is the radical -COOR.sub.1,-CR.sub.1 O,-CONHNHR.sub.1,-CON(R.sub.1)(R.sub.2) or -CH.sub.2 OR.sub.1, with R.sub.1 and R.sub.2 being lower alkyl or hydrogen. These peptides or biologically active fragments thereof, or analogs thereof having well-known substitutions and/or additions, as well as nontoxic salts of any of the foregoing, may be administered therapeutically to animals, including humans, and may be used diagnostically.
REFERENCES:
patent: 4218474 (1980-08-01), Barnish et al.
Esch et al., Biochemical and Biophysical Research Communications, 109, No. 1, 152-158 (1982).
Esch et al., The Journal of Biological Chemistry, 258, No. 3, 1806-1812 (1983).
Li et al., J. Am. Chem. Soc., 92:26 (1970) pp. 7608-7609.
Veber et al., Biochem. & Biophys. Res. Commun., 45, No. 1, 235-9 (1971).
Frohman et al., Clin. Invest., 65, 43-54 (1980).
Spiess et al., Biochemistry, vol. 21, 1982, pp. 6037-6040.
Spiess et al., Nature, vol. 303, 1983, pp. 532-535.
Tharner et al., The Lancet, Jan. 1/8, 1983, pp. 24-28.
Rivier et al., 8th American Peptide Symposium, May 22-27, 1983, Tucson, Arizona, p. 237.
Spiess et al., Biochemistry, 21, 6037-6040 (1982).
Spiess et al., Nature, 303 (9), 532-535 (1983).
Tharner et al., The Lancet, No. 831415, 24-28 (1983).
Rivier Jean E. F.
Spiess Joachim
Vale, Jr. Wylie W.
Moezic F. T.
Phillips Delbert R.
The Salk Institute for Biological Studies
LandOfFree
Human pancreatic GRF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human pancreatic GRF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human pancreatic GRF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-111387